Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
53,000
Employees53,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
53,000
Employees53,000

BSX Key Statistics

Market cap
142.09B
Market cap142.09B
Price-Earnings ratio
57.55
Price-Earnings ratio57.55
Dividend yield
Dividend yield
Average volume
11.80M
Average volume11.80M
High today
$97.21
High today$97.21
Low today
$95.39
Low today$95.39
Open price
$96.70
Open price$96.70
Volume
8.18M
Volume8.18M
52 Week high
$109.50
52 Week high$109.50
52 Week low
$80.64
52 Week low$80.64

BSX News

Simply Wall St 1d
Boston Scientific: Evaluating Valuation as Analyst Confidence Remains High Following Strong Segment Growth and Innovation

Boston Scientific (BSX) recently took center stage at the MEDevice Boston conference, where company leaders Ann Roy and Liza Davis highlighted the latest develo...

Boston Scientific: Evaluating Valuation as Analyst Confidence Remains High Following Strong Segment Growth and Innovation
Nasdaq 1d
Peter Lynch Detailed Fundamental Analysis - BSX

Below is Validea's guru fundamental report for BOSTON SCIENTIFIC CORP (BSX). Of the 22 guru strategies we follow, BSX rates highest using our P/E/Growth Investo...

Peter Lynch Detailed Fundamental Analysis - BSX
Simply Wall St 4d
How Are Analysts Weighing Boston Scientific’s Innovation Pipeline Against Market Execution Strategies?

At the MEDevice Boston conference on September 30, 2025, Boston Scientific highlighted ongoing product advances and market access strategies, with insights from...

How Are Analysts Weighing Boston Scientific’s Innovation Pipeline Against Market Execution Strategies?

Analyst ratings

95%

of 37 ratings
Buy
94.6%
Hold
5.4%
Sell
0%

More BSX News

TipRanks 4d
Boston Scientific downgraded to Hold from Buy at Erste Group

Erste Group downgraded Boston Scientific (BSX) to Hold from Buy. The company’s sales growth will be lower in 2026 than in 2025 and stock is expensive relative t...

TipRanks 6d
Boston Scientific price target raised to $132 from $127 at BTIG

BTIG raised the firm’s price target on Boston Scientific (BSX) to $132 from $127 and keeps a Buy rating on the shares. The firm notes the company’s biennial inv...

TipRanks 7d
Boston Scientific’s Promising Growth Trajectory: Buy Rating Supported by Innovative Products and Strategic Expansion

Needham analyst Michael Matson reiterated a Buy rating on Boston Scientific today and set a price target of $121.00. Elevate Your Investing Strategy: Take advan...

TipRanks 7d
Strong Buy Rating for Boston Scientific: Promising Growth and Profitability Outlook

Boston Scientific, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Danielle Antalffy from UBS maintained a Buy rating o...

TipRanks 7d
Boston Scientific: Strong Growth Prospects and Strategic Initiatives Drive Buy Rating

In a report released yesterday, Joanne Wuensch from Citi maintained a Buy rating on Boston Scientific, with a price target of $125.00. Elevate Your Investing St...

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.